ERBB2 and breast carcinoma: Indeed, cats with luminal B or HER2-positive mammary carcinoma showed significantly lower serum leptin levels when compared with controls (p < 0.001 and p < 0.05, respectively), revealing that serum leptin levels are downregulated in tumors with PR-positive status (14) and/or HER2-positive status (27).